Benzylidine indane-1,3-diones: As novel urease inhibitors; synthesis, in vitro, and in silico studies
摘要:
Current study deals with the evaluation of indane-1,3-dione based compounds as new class of urease inhibitors. For that purpose, benzylidine indane-1,3-diones (1-30) were synthesized and fully characterized by different spectroscopic techniques including EI-MS, HREI-MS, H-1, and C-13 NMR. All synthetic molecules 1-30 were evaluated for urease inhibitory activity and showed good to moderate inhibitory potential within the range of (IC50 = 11.60 +/- 0.3-257.05 +/- 0.7 mu M) as compared to the standard acetohydroxamic acid (IC50 = 27.0 +/- 0.5 mu M). Compound 1 (IC50 = 11.60 +/- 0.3 mu M) was found to be most potent inhibitor amongst all derivatives. The key binding interactions of most active compounds within the enzyme pocket were evaluated through in silico studies.
Agranat,I. et al., Israel Journal of Chemistry, 1969, vol. 7, p. 89 - 97
作者:Agranat,I. et al.
DOI:——
日期:——
De Winter; Nauta, European Journal of Medicinal Chemistry, 1977, vol. 12, # 2, p. 125 - 130
作者:De Winter、Nauta
DOI:——
日期:——
Benzylidine indane-1,3-diones: As novel urease inhibitors; synthesis, in vitro, and in silico studies
作者:Bilquees Bano、Kanwal、Khalid Mohammed Khan、Farida Begum、Muhammad Arif Lodhi、Uzma Salar、Ruqaiya Khalil、Zaheer Ul-Haq、Shahnaz Perveen
DOI:10.1016/j.bioorg.2018.09.030
日期:2018.12
Current study deals with the evaluation of indane-1,3-dione based compounds as new class of urease inhibitors. For that purpose, benzylidine indane-1,3-diones (1-30) were synthesized and fully characterized by different spectroscopic techniques including EI-MS, HREI-MS, H-1, and C-13 NMR. All synthetic molecules 1-30 were evaluated for urease inhibitory activity and showed good to moderate inhibitory potential within the range of (IC50 = 11.60 +/- 0.3-257.05 +/- 0.7 mu M) as compared to the standard acetohydroxamic acid (IC50 = 27.0 +/- 0.5 mu M). Compound 1 (IC50 = 11.60 +/- 0.3 mu M) was found to be most potent inhibitor amongst all derivatives. The key binding interactions of most active compounds within the enzyme pocket were evaluated through in silico studies.
WINTER M. L. DE; NAUTA W. T., EUR. J. MED. CHEM., 1977, 12, NO 2, 125-130